How is QR678® different from EXOSOMES?

Recent times have seen a whirlwind in the newer technologies being introduced in the hair market. The wave of regenerative medicine has extended its tide to include conditions of hair loss such as Androgenetic Alopecia and Telogen Effluvium. An example of one such advancement is Exosome Therapy.
Exosomes are extracellular vesicles carrying genetic information and proteins. These proteins, theorised to be growth factors, may play a crucial role in the hair growth cycle. Exosome therapeutics in regenerative medicine for hair loss treatment promote cellular regeneration and microenvironmental modulation, thereby encouraging dormant hair follicles to re-enter the growth phase.

QR678®

The QR678 research & development platform technology is a proprietary first-in-class technology. This science backed technology is giving rise to multiple products that arrest hair fall and address the thickness, density of hair follicles leading to greater coverage in hair loss. This R&D technology deals with multiple human hair growth related growth factors that are naturally present in our scalp making products derived from these completely natural. Research on this platform technology has resulted in this being awarded USA & Indian patents and has led to over 13+ clinical research papers being published with products derived from this unique technology. The hair growth factors penetrate deep into the scalp and provide nourishment to the scale. Unlike other treatments that contains harmful medication, products derived from QR678 are almost completely devoid of side effects.

Exosomes

QR678 Neo vs Exosomes

Exosomes are ‘signaling molecules’ that are injected into the scalp to trigger the secretion of growth factors. They are protein building blocks due to the presence of mRNA in their membrane. This mRNA synthesizes proteins according to its cell of origin. Therefore, when extracted from hair follicles, exosomes facilitate hair growth and can help prevent hair loss.

Exosomes: Promises or Pitfalls?

Although promising on paper, the research behind the rationale for exosome treatment is on-going. There is still a lot to learn about the efficacy and mechanism of action of exosome therapy. There is a need for reliable evidence in the form of research studies published in peer-reviewed journals with appropriate methodology to back the advent of exosome therapy for treatment of hair loss.

In the year 2019, the U.S. Food and Drug Administration issued a Public Safety Notification on exosome products stating the violative nature of “stem cells” products and their unsubstantiated claims in treating various conditions. The FDA clarified that currently there is no FDA-approved exosome product in the market.

How is QR678® different from Exosomes?

  QR678® Derived Products  Exosomes
Source Plant-derived- no need to withdraw blood / tissue Human tissue- punch biopsy is done to withdraw the tissue sample
Contents Growth factors specifically targeted for hair health mRNA and proteins
Pain Painless application  Painful procedure- subdermal injections are given
Procedure Time No procedure time Over 30-40 minutes of preparation time required
Research 13+ research papers published in top international peer-reviewed journals Lack of evidence to support efficacy
[elementor-template id="12798"]